NCT00444041 Pre- and Postoperative Chemotherapy Including Bevacizumab in Potentially Curable Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00435097 Computer Assisted Early Detection of Liver Metastases From fMRI Maps Status UNKNOWN Phase N/A
NCT00422773 Safety of Cetuximab and Oxaliplatin/5-FU/FA/Irinotecan in First-Line Treatment of Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00418938 SPIRITT - Second-Line Panitumumab Irinotecan Treatment Trial Status COMPLETED Phase PHASE2
NCT00414492 Pattern of Cell Death Following Neoadjuvant Therapy for Metastatic Colon Cancer Status COMPLETED Phase N/A
NCT00411450 Panitumumab Regimen Evaluation in Colorectal Cancer to Estimate Primary Response to Treatment Status COMPLETED Phase PHASE2
NCT00399035 Cediranib (AZD2171, RECENTIN™) in Addition to Chemotherapy in Patients With Untreated Metastatic Colorectal Cancer Status COMPLETED Phase PHASE3
NCT00378066 Phase II Study of Bevacizumab, Capecitabine and Oxaliplatin in Colon Cancer Status COMPLETED Phase PHASE2
NCT00364013 PRIME: Panitumumab Randomized Trial In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy Status COMPLETED Phase PHASE3
NCT00345696 1stline Study Capecitabine Administered on Continuous Way Plus Oxaliplatin&Bevacizumab Every 2weeks in Metastatic CCR. Status COMPLETED Phase PHASE2
NCT00339183 Comparison of Treatment Effect of Chemotherapy With Panitumumab to Chemotherapy Alone Status COMPLETED Phase PHASE3
NCT00337389 Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer. Status UNKNOWN Phase PHASE3
NCT00332163 Skin Toxicity Treatment in Metastatic Colorectal Cancer (mCRC) Patients Receiving Panitumumab + Irinotecan-based Therapy Status COMPLETED Phase PHASE2
NCT00327119 Phase 2 Study of ABX-EGF (Panitumumab) in Japanese Subjects With M-colorectal Cancer Status COMPLETED Phase PHASE2
NCT00316745 IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer Status SUSPENDED Phase PHASE3
NCT00294359 The MAX Study: Mitomycin C, Avastin and Xeloda in Patients With Untreated Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2/PHASE3
NCT00286130 Safety and Efficacy of Folfox6 + Cetuximab Versus Folfiri +Cetuximab in Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00255229 Study of Glutamine as Prophylaxis for Irinotecan Induced Diarrhea Status COMPLETED Phase PHASE2